Large portions of the general population will not only experience a form of mental illness during the course of their lifetime, but will also experience some form of addiction. Drug addiction is a chronic relapsing disorder characterized by compulsive uncontrollable use of a drug. Addiction occurs in three stages: the preoccupation and anticipation stage; the stage of "binge," or intoxication stage; and the withdrawal negative affect stage. These stages of addiction also occur with legalized drugs like tobacco and alcohol. The greatest functional impairment occurs among chronic users of tobacco or among repeatedly binging or chronic users of alcohol. Of course, heroin addiction can also produce functional impairment, but the number of people estimated to have ever used heroin in the United States is 1.5 million, while alcohol users, for example, number 91.5 million (Table 1) . Therefore, these drugs, being more accessible, negatively affect a far larger population.
Drug addiction has been categorized as a brain disease, much like eating disorders or depression. The major dysfunction and deregulation associated with addictive disorders involve the brain's natural reward system, a system presumably important for guiding homeostatic regulating behavior, e.g., seeking and obtaining food and shelter and reproducing. In other words, all drugs of addiction, when taken acutely or in a one-time high dosage, activate brain systems involved in processing natural rewards. When taken chronically or regularly over a period, they deregulate these reward systems. Neurochemical systems activated by drugs of addiction and responsible for the acute pleasurable effects of drugs include those activated by dopamine, opioid peptides (enkephalins and endorphins), serotonin (5-HT), and ␥-aminobutyric acid (GABA). Chronic administration of addictive drugs compromises the function of these reward transmitters but also recruits activation of brain stress systems such as corticotropin-releasing factor (CRF). Thus, the disorder actually becomes more acute over time with escalating drug use.
Much of the most revealing research in drug addiction has been performed in rodent models. Researchers study the interaction of the drugs with transmitter messenger systems in specific brain regions. Drugs can interfere with the normal activation, storage, uptake, and release of these crucial systems.
NEUROBIOLOGICAL BASIS FOR ACUTE DRUG REINFORCEMENT
A classic experiment using a rodent animal model exposed to cocaine or alcohol administration demonstrates the acute reinforcing effects of addictive drugs. In the experiment, the rat self-administers cocaine or ethanol by pressing a lever, and thereby injects the drug via an intravenous catheter. Dopamine release is measured by inserting a microdialysis probe into the nucleus accumbens. The probe has a very small semipermeable membrane at the tip, through which dopamine can pass, accumulate, and be measured. One of the major actions of cocaine is on monoamine transporter mechanisms to block the reuptake of dopamine in an area called the nucleus accumbens, part of the mesolimbic dopamine system. Following cocaine administration, more dopamine is allowed into the synapse, and the brain experiences amplified and extended effects of this neurotransmitter, resulting in an amplified pleasurable experience. In the case of ethanol administration, numerous transmitters including dopamine undergo changes in the nucleus accumbens and the amygdala ( Table 2) .
The above experiment proves the obvious: people use drugs based on a pleasurable activation of the brain's reward system. But how does this lead to addiction? How does this model change with chronic administration of drugs? Clearly, not all 91.5 million people who have used alcohol at least once in their lifetime become addicted. The major questions are where the vulnerability lies-why some people become addicted and others do not and how the brain
